BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gábor Hutóczki, József Virga, Zsuzsanna Birkó, Almos Klekner. Novel Concepts of Glioblastoma Therapy Concerning Its Heterogeneity. Int J Mol Sci 2021;22:10005. [PMID: 34576168 DOI: 10.3390/ijms221810005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Fan Z, Meng Y, Liu S, Zhan H. Blood-based DNA methylation signatures in cancer: A systematic review. Biochim Biophys Acta Mol Basis Dis 2023;1869:166583. [PMID: 36270476 DOI: 10.1016/j.bbadis.2022.166583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Noushmehr H, Herrgott G, Morosini NS, Castro AV. Noninvasive approaches to detect methylation-based markers to monitor gliomas. Neuro-Oncology Advances 2022;4:ii22-ii32. [DOI: 10.1093/noajnl/vdac021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Valiulyte I, Pranckeviciene A, Bunevicius A, Tamasauskas A, Svitina H, Skrypkina I, Vaitkiene P. Associations of miR-181a with Health-Related Quality of Life, Cognitive Functioning, and Clinical Data of Patients with Different Grade Glioma Tumors. IJMS 2022;23:11149. [DOI: 10.3390/ijms231911149] [Reference Citation Analysis]
4 Ruggiero MR, Ait Itto H, Baroni S, Pierre S, Boutonnat J, Broche LM, Aime S, Berger F, Geninatti Crich S, Lahrech H. Role of Transmembrane Water Exchange in Glioma Invasion/Migration: In Vivo Preclinical Study by Relaxometry at Very Low Magnetic Field. Cancers (Basel) 2022;14. [PMID: 36077717 DOI: 10.3390/cancers14174180] [Reference Citation Analysis]
5 Barzegar Behrooz A, Talaie Z, Syahir A. Nanotechnology-Based Combinatorial Anti-Glioblastoma Therapies: Moving from Terminal to Treatable. Pharmaceutics 2022;14:1697. [DOI: 10.3390/pharmaceutics14081697] [Reference Citation Analysis]
6 Xu W, Huang L, Xie B, Yang B. Serum microRNA-4297 is a sex-specific predictive biomarker of glioma grade and prognosis. Front Neurol 2022;13:888221. [DOI: 10.3389/fneur.2022.888221] [Reference Citation Analysis]
7 Wang M, Chen B, Zhang W, Zhang F, Qiu Y, Lin Y, Yang S. Dematin inhibits glioblastoma malignancy through RhoA-mediated CDKs downregulation and cytoskeleton remodeling. Exp Cell Res 2022;:113196. [PMID: 35561787 DOI: 10.1016/j.yexcr.2022.113196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Yang Y, Tu Y, Lu J, Chen Q, Zhu Z, Peng W, Zhu W, Wen S, Zhang J, Yin W, Pi R. PT109, a novel multi-kinase inhibitor suppresses glioblastoma multiforme through cell reprogramming: Involvement of PTBP1/PKM1/2 pathway. Eur J Pharmacol 2022;920:174837. [PMID: 35218719 DOI: 10.1016/j.ejphar.2022.174837] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sita G, Graziosi A, Hrelia P, Morroni F. Sulforaphane Causes Cell Cycle Arrest and Apoptosis in Human Glioblastoma U87MG and U373MG Cell Lines under Hypoxic Conditions. Int J Mol Sci 2021;22:11201. [PMID: 34681862 DOI: 10.3390/ijms222011201] [Cited by in F6Publishing: 3] [Reference Citation Analysis]